Investment
Features
FeesSafety
Academy
More
Pluang+

BFA Law investigates $8.05/share take-private deal of Priority Technology for fairness to minority shareholders.

Market News
06 Oct 2026
PRNewsWire
View Source
Bearish
BFA Law investigates $8.05/share take-private deal of Priority Technology for fairness to minority shareholders.

BFA Law is investigating the $8.05 per share take-private acquisition of Priority Technology Holdings by its controlling shareholder Thomas Priore. The law firm is examining whether the deal terms are fair to minority shareholders and if the approval process sufficiently protects their rights. Minority shareholders are encouraged to contact BFA Law as there may be legal options if fiduciary duties were breached. The investigation aims to ensure minority interests are safeguarded in this transaction.

The investigation into Priority Technology's $8.05 per share take-private deal is presented here with Pluang's Technology sector market data as context. For readers following Technology stocks, as of Oct 06, 2026 15:02 WIB, 96 of 150 priced US Technology stocks rose while 45 fell. Notably, Hewlett Packard Enterprise Co (HPE) traded at USD 69.40 with a 1-day gain of 1.49% and a typical hold time of 34 days, contrasting with Firy Inc. (FIRY) at USD 12.40, down 1.35%, and Marqeta Inc. (MQ) at USD 16.81, down 1.29%, with hold times of 13 and 43 days respectively.

More News

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...

Analyst Insights
Neutral
3 hours ago
IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical has expanded its U.S. clinical network for the ChoICE Study by adding Legacy Health in Oregon as a new site. The study evaluates the safety and effectiveness of ProSense® cryoablation, a minimally invasive treatment for low-risk breas...

Market News
Bullish
4 hours ago
Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir Technologies saw its stock rise 60.3% in the third quarter, marking its strongest quarterly gain since mid-2025, driven by a 93% revenue increase to $1.935 billion and a 149% jump in U.S. commercial revenue. Despite this surge, Palantir is o...

Company Fundamentals
Bullish
4 hours ago
Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares are performing poorly this year, reflecting investor skepticism due to the company's struggling operating results. Despite the negative sentiment, analyst Justin Purohit believes that long-term investors could benefit from holding onto or...

Analyst Insights
Bullish
4 hours ago
Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano's ADA price climbed to around $0.279, approaching the $0.28 resistance level after gaining nearly 9% in a week. The rally is supported by increased derivatives open interest and whale transactions, indicating new leveraged bets entering the m...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App